Filings

8 documents · 27 matches

1. MLTX MoonLake Immunotherapeutics 10-Q 2026-08-10

   Item 1A. Risk Factors

   tariffs, the duration of existing tariffs, tariff levels, and whether additional tariffs or other retaliatory actions may be imposed, modified
   4 matches in this document Show context Copy citation

2. MLTX MoonLake Immunotherapeutics 10-K 2026-02-25

   Item 1A. Risk Factors

   tariffs, tariff levels, implementation of announced tariffs, litigation challenging tariffs and whether additional tariffs or retaliatory actions may be imposed
   5 matches in this document Show context Copy citation

3. MLTX MoonLake Immunotherapeutics 10-Q 2025-08-05

   Item 1A. Risk Factors

   tariffs on imports from most countries, including significant tariffs on imports from China. Historically, tariffs have led to increased trade
   4 matches in this document Show context Copy citation

4. MLTX MoonLake Immunotherapeutics 10-Q 2025-05-12

   Item 1A. Risk Factors

   tariffs on imports from most countries, including significant tariffs on imports from China. Historically, tariffs have led to increased trade
   4 matches in this document Show context Copy citation

5. MLTX MoonLake Immunotherapeutics 10-Q 2026-05-11

   Item 1A. Risk Factors

   tariffs and, more generally, about the duration of existing tariffs, tariff levels, and whether additional tariffs or retaliatory actions may be imposed
   4 matches in this document Show context Copy citation

6. MLTX MoonLake Immunotherapeutics 10-Q 2025-11-05

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs, which in turn has led and could lead to further retaliatory tariffs. These may have the potential to impact
   2 matches in this document Show context Copy citation

7. MLTX MoonLake Immunotherapeutics 8-K 2025-08-05

   tariffs and potential additional tariffs, FDA and comparable foreign regulatory authorities changes in leadership or policies or issuing additional regulations
   1 match in this document Show context Copy citation

8. MLTX MoonLake Immunotherapeutics 10-Q 2026-11-04

   Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

   tariffs and other barriers to trade, changes in fiscal and monetary policy or government budget dynamics, the prospect of a shutdown
   3 matches in this document Show context Copy citation